JANE STREET GROUP, LLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Back to TVTX Full portfolio

Position in TVTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$53,327,489

+$44,346,752 QoQ

Shares Held

938,699

+210.5% QoQ

Ownership

0.996%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#30

of 317 holders

Holding Since

Sep 2020

22 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Derivatives in TVTX

reported options exposure · as of Jun 30, 2026

CallValue

$6,044,584

CallShares

106,400

PutValue

$17,332,731

PutShares

305,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. TVTX ranks #8 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	2,934,193	$218,538,693
2	MDGL	Madrigal Pharmaceuticals, Inc.	191,541	$102,847,939
3	AXSM	Axsome Therapeutics, Inc.	403,995	$98,885,855
4	TGTX	Tg Therapeutics, Inc.	1,752,646	$96,290,370
5	EXEL	Exelixis, Inc.	1,402,438	$76,306,651
6	QURE	uniQure N.V.	1,610,483	$74,178,846
7	HALO	Halozyme Therapeutics, Inc.	694,684	$54,372,915
8	TVTX	Travere Therapeutics, Inc. This page	938,699	$53,327,489

All Filings in TVTX

Export CSV

39 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,044,584	106,400	-44.5%	Call	Defined	2026-08-14
2026-06-30	$17,332,731	305,100	+529.1%	Put	Defined	2026-08-14
2026-06-30	$53,327,489	938,699	+210.5%	Shares	Defined	2026-08-14
2026-03-31	$8,980,737	302,280	-22.9%	Shares	Defined	2026-05-12
2026-03-31	$5,692,436	191,600	-25.4%	Call	Defined	2026-05-12
2026-03-31	$1,440,935	48,500	+18.0%	Put	Defined	2026-05-12
2025-12-31	$14,988,751	392,273	+444.7%	Shares	Defined	2026-02-12
2025-12-31	$9,812,328	256,800	-20.3%	Call	Defined	2026-02-12
2025-12-31	$1,570,431	41,100	-40.3%	Put	Defined	2026-02-12
2025-09-30	$1,646,710	68,900	-83.3%	Put	Defined	2025-11-14
2025-09-30	$7,700,580	322,200	-33.7%	Call	Defined	2025-11-14
2025-06-30	$7,195,760	486,200	+137.2%	Call	Defined	2025-08-14
2025-03-31	$3,673,600	205,000	-21.8%	Call	Defined	2025-05-19
2025-03-31	$7,413,504	413,700	-24.3%	Put	Defined	2025-05-19
2025-03-31	$1,290,562	72,018	+9.6%	Shares	Defined	2025-05-19
2024-12-31	$9,521,772	546,600	-1.3%	Put	Defined	2025-02-14
2024-12-31	$1,144,319	65,690	-78.9%	Shares	Defined	2025-02-14
2024-12-31	$4,569,266	262,300	+173.5%	Call	Defined	2025-02-14
2024-09-30	$1,341,641	95,900	+129.4%	Call	Defined	2024-11-15
2024-09-30	$4,354,526	311,260	-24.1%	Shares	Defined	2024-11-15
2024-09-30	$7,746,263	553,700	+5984.6%	Put	Defined	2024-11-15
2024-06-30	$3,369,024	409,857	+5.3%	Shares	Defined	2024-08-15
2024-03-31	$3,000,792	389,208	+54.4%	Shares	Defined	2024-05-16
2023-12-31	$2,266,377	252,100	+50.5%	Shares	Defined	2024-02-15
2023-09-30	$1,497,860	167,546	+146.4%	Shares	Defined	2023-11-15
2023-06-30	$1,044,264	67,986	-71.8%	Shares	Defined	2023-08-14
2023-03-31	$5,425,577	241,244	+761.8%	Shares	Defined	2023-05-16
2022-06-30	$678,294	27,994	+177.1%	Shares	Defined	2022-08-16
2022-03-31	$1,077,186	41,800	+89.1%	Call	Defined	2022-05-17
2022-03-31	$234,507	9,100	+40.0%	Put	Defined	2022-05-17
2021-12-31	$201,760	6,500	-52.9%	Put	Defined	2022-02-15
2021-12-31	$685,984	22,100	—	Call	Defined	2022-02-15
2021-12-31	$313,628	10,104	-3.0%	Shares	Defined	2022-02-15
2021-09-30	$252,636	10,418	-84.9%	Shares	Defined	2021-11-16
2021-06-30	$201,342	13,800	—	Put	Defined	2021-08-16
2021-06-30	$1,005,892	68,944	+617.5%	Shares	Defined	2021-08-16
2021-03-31	$239,935	9,609	-49.9%	Shares	Defined	2021-05-18
2020-12-31	$522,669	19,177	—	Shares	Defined	2021-02-17
2020-09-30 RTRX	—	17,645	—	Shares	Defined	2020-11-17
No filing history on record for this holder in this stock.